Abstract
Two neonates with complex cyanotic congenital heart disease, receiving long-term prostaglandin E1 infusion, for 59 and 78 days respectively, demonstrated significant radiographic changes of symmetric cortical hyperostosis of the long bones. Bone biopsies from one of the patients elucidated the histological changes and serial X-rays revealed regression of the hyperostosis. Long-term follow-up after 13 months did not reveal any late bony changes or growth disturbance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Elliott RB, Starling MB, Neutze JM (1975) Medical manipulation of the ductus arteriosus. Lancet 1: 140
Olley PM, Coceani F, Bodach E (1976) E-type prostaglandins. A new emergency therapy for certain cyanotic congenital heart malformations. Circulation 53: 728
Neutze JM, Starling MB, Elliott RB, Barratt-Boyes BG (1977) Palliation of cyanotic heart disease in infancy with E-type prostaglandins. Circulation 55: 238
Pitlick P, French JW, Maze A, Kimble KJ, Ariagno RL, Rutz BA (1980) Long-term low-dose prostaglandin E1 administration. J Pediatr 96: 318
Lewis AB, Lurie PR (1978) Prolonged prostaglandin E1 infusion in an infant with cyanotic congenital heart disease. Pediatrics 61: 534
Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, Twaya T (1980) Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 97: 834
Sone K, Tashiro M, Fyjinaga T, Tomomasa T, Tokuyama K, Kuroume T (1980) Long-term low-dose prostaglandin E1 administration. J Pediatr 97: 866
Ringel RE, Brenner JJ, Haney PJ, Burns JE, Moulton AL, Berman MA (1982) Prostaglandin-induced periostitis. A complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology 142: 657
Hoevels-Guerich H, Haferkorn L, Persigehl M, Hofstetter R, von Bernuth G (1984) Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infants. J Pediatr 105: 72
Coe JY, Silove ED (1979) Oral prostaglandin E2 in pulmonary atresia. Lancet 1: 1297
Caffey J, Silvermann WA (1945) Infantile cortical hyperostoses. Preliminary report on a new syndrome. Am J Roentgenol Rad Ther 54: 1
Silove E, Roberts DGV, De Giovanni JV (1985) Evaluation of oral and low-dose intravenous prostaglandin E2 in management of ductus-dependent congenital heart disease. Arch Dis Child 60: 1025
Feyen JHM, Bon AD, Plas A, Lowick CWGM, Nijweide PJ (1985) Effects of exogenous prostanoids on the proliferation of osteoblast-like cells in vitro. Prostaglandins 30: 827
Jee 6SS, Ueno K, Haba T, Deng YP (1984) Prostaglandin E2-induced bone changes in growing rats. Calcif Tissue Int 36 [Suppl]: 2
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Høst, A., Halken, S. & Andersen, P.E. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease. Pediatr Radiol 18, 149–153 (1988). https://doi.org/10.1007/BF02387559
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02387559